481 filings
Page 19 of 25
424B5
u054bagvc0d pxca9ow
25 Sep 19
Prospectus supplement for primary offering
4:58pm
8-K
3b7w1n2uwpv4as npufs
25 Sep 19
Termination of a Material Definitive Agreement
4:20pm
4
x01dfgv080r72 wkom
26 Aug 19
BioXcel Therapeutics / PETER MUELLER ownership change
5:38pm
4
p21l0c3nkg ptll
23 Aug 19
BioXcel Therapeutics / PETER MUELLER ownership change
4:26pm
4
mmackeh e0iexq
19 Aug 19
BioXcel Therapeutics / Vimal Mehta ownership change
4:16pm
4
z73zelxy ndnmc
16 Aug 19
BioXcel Therapeutics / Vimal Mehta ownership change
12:00am
4
4xxp r8wzu
14 Aug 19
BioXcel Therapeutics / Vimal Mehta ownership change
4:15pm
4
g66wuj12e4d0p
14 Aug 19
BioXcel Therapeutics / Frank Yocca ownership change
12:00am
8-K
ij5gmapcd40 bh
6 Aug 19
BioXcel Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
8:06am
8-K
4golr
22 Jul 19
Regulation FD Disclosure
9:29am
4
dicnc8u85wk
19 Jun 19
BioXcel Therapeutics / Michal Votruba ownership change
9:07pm
8-K
993c3jl1jfr v4g
29 May 19
Submission of Matters to a Vote of Security Holders
5:05pm
4
setl4pwb
28 May 19
BioXcel Therapeutics / Sandeep Laumas ownership change
9:01pm
4
5jw8yqzpa ac0rp7avp
28 May 19
BioXcel Therapeutics / PETER MUELLER ownership change
9:00pm
4
m7s3n
28 May 19
BioXcel Therapeutics / Vimal Mehta ownership change
8:59pm
8-K
nbjoejj smuru5
22 May 19
Regulation FD Disclosure
6:10am
8-K
n2jui nd0994
20 May 19
Entry into a Material Definitive Agreement
9:28am
424B5
hrlp5r acfk90s
20 May 19
Prospectus supplement for primary offering
9:18am
8-K
v7zmnljcj5ufcrwy
20 May 19
BioXcel Therapeutics Achieved Targeted Exposures of BXCL501 Designed For Non-Invasive Acute Treatment of Agitation in Neuropsychiatric Diseases
9:04am